Litcius/Paper detail

Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial

Yan Lou, Lin Liu, Hangping Yao, Xingjiang Hu, Junwei Su, Kaijin Xu, Rui Luo, Xi Yang, Lingjuan He, Xiaoyang Lu, Qingwei Zhao, Tingbo Liang, Yunqing Qiu

2020European Journal of Pharmaceutical Sciences181 citationsDOIOpen Access PDF

Topics & Concepts

FavipiravirMedicineRandomized controlled trialLopinavirClinical trialRandomizationInternal medicineViral loadDoseClinical endpointPharmacologyCoronavirus disease 2019 (COVID-19)VirusVirologyDiseaseInfectious disease (medical specialty)Antiretroviral therapyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchRespiratory viral infections research
Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial | Litcius